FeatureName:distant_metastasis_pathologic_spread|Type:BIN|StatisticMethod:ranktest|GroupComparison:m0/m1|Statistics: 259.000000|Direction:-1|PValue:3.11033e-02|FDR:0.201528406;FeatureName:lymphatic_invasion_present|Type:BIN|StatisticMethod:ranktest|GroupComparison:yes/no|Statistics:1072.000000|Direction: 1|PValue:2.53821e-02|FDR:0.352811156;FeatureName:residual_tumor|Type:CAT|StatisticMethod:kruskal|GroupComparison:r0/r2/rx/r1|Statistics:   9.744627|Direction: 1|PValue:2.08664e-02|FDR:0.170613664;FeatureName:vascular_Invasion|Type:BIN|StatisticMethod:ranktest|GroupComparison:no/yes|Statistics: 242.000000|Direction:-1|PValue:3.89993e-02|FDR:0.557325344;FeatureName:MSI_status_TCGAPaper_twogroup|Type:BIN|StatisticMethod:ranktest|GroupComparison:MSS/MSI|Statistics: 905.000000|Direction: 1|PValue:2.29656e-02|FDR:0.098859724;FeatureName:MLH1_silencing|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 579.000000|Direction: 1|PValue:9.73215e-03|FDR:0.070476828;FeatureName:hypermutated|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 722.000000|Direction: 1|PValue:7.57475e-04|FDR:0.004785865;FeatureName:silent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.496760|Direction:-1|PValue:9.06417e-06|FDR:0.000203381;FeatureName:nonsilent_mutrate|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.370879|Direction:-1|PValue:1.34061e-03|FDR:0.010961495;FeatureName:SYNE1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 884.000000|Direction: 1|PValue:3.11599e-02|FDR:0.397935225;FeatureName:TP53_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 673.000000|Direction:-1|PValue:4.32582e-02|FDR:0.146252331;FeatureName:RYR1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 749.000000|Direction: 1|PValue:9.98163e-03|FDR:0.239847545;FeatureName:TTN_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 617.000000|Direction:-1|PValue:1.59480e-02|FDR:0.221677382;FeatureName:FAT2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 637.000000|Direction: 1|PValue:1.22367e-02|FDR:0.300218637;FeatureName:MUC16_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 929.000000|Direction: 1|PValue:1.47079e-03|FDR:0.021200809;FeatureName:PIK3CA_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:1/0|Statistics: 331.000000|Direction:-1|PValue:1.31775e-02|FDR:0.832000576;FeatureName:CSMD1_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 768.000000|Direction: 1|PValue:1.54046e-02|FDR:0.522931008;FeatureName:CSMD2_mutation|Type:BIN|StatisticMethod:ranktest|GroupComparison:0/1|Statistics: 629.000000|Direction: 1|PValue:3.73123e-03|FDR:0.390939989;FeatureName:20q11.21_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.329061|Direction: 1|PValue:1.74570e-03|FDR:0.007582885;FeatureName:20q12_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.370720|Direction: 1|PValue:3.77244e-04|FDR:0.002097477;FeatureName:13q12.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.362094|Direction: 1|PValue:5.27099e-04|FDR:0.010328381;FeatureName:13q12.13_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.393545|Direction: 1|PValue:1.48681e-04|FDR:0.004133325;FeatureName:13q22.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.396393|Direction: 1|PValue:1.31736e-04|FDR:0.003051884;FeatureName:6p21.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.315324|Direction: 1|PValue:2.76757e-03|FDR:0.053020945;FeatureName:20q13.31_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.342647|Direction: 1|PValue:1.08357e-03|FDR:0.005193676;FeatureName:16p11.2_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.290070|Direction: 1|PValue:6.11787e-03|FDR:0.023709488;FeatureName:2q33.1_Amplification|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.255009|Direction: 1|PValue:1.64950e-02|FDR:0.351583242;FeatureName:16q23.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.324084|Direction: 1|PValue:2.06794e-03|FDR:0.014121096;FeatureName:1p33_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.226977|Direction:-1|PValue:3.34509e-02|FDR:0.290604681;FeatureName:1p36.11_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.329003|Direction:-1|PValue:1.74918e-03|FDR:0.020261373;FeatureName:6p25.3_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.254950|Direction: 1|PValue:1.65205e-02|FDR:0.453146691;FeatureName:8p22_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.228137|Direction:-1|PValue:3.25337e-02|FDR:0.223674567;FeatureName:18q22.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.218437|Direction:-1|PValue:4.08958e-02|FDR:0.102548127;FeatureName:7q31.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:   0.219053|Direction: 1|PValue:4.03165e-02|FDR:0.221146743;FeatureName:15q21.1_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.230511|Direction:-1|PValue:3.07217e-02|FDR:0.355859953;FeatureName:18p11.31_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.272299|Direction:-1|PValue:1.02713e-02|FDR:0.035692623;FeatureName:1p13.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.223133|Direction:-1|PValue:3.66473e-02|FDR:0.221477446;FeatureName:14q21.2_Deletion|Type:CON|StatisticMethod:spearman|GroupComparison:|Statistics:  -0.338546|Direction:-1|PValue:1.25415e-03|FDR:0.029054480